Compugen (CGEN) Stock Price, Quote, News & History

Key Statistics

Open

$2.30

Volume / Avg.

188.67K / 254.90K

Day Range

$2.25 - $2.32

52 Wk Range

1.43 - 3.24

Market Cap

$216.53M

P/E Ratio

6.08

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.61%

Days to Cover

12.01

Recent Compugen Ltd. News

This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Avi Kapoor

Alterity Up on Interim Data From Advance MSA Study

Shares of Alterity Therapeutics (NASDAQ: ATHE) were up 7.8% on Jul 17 after the company announced positive interim data from the phase II ATH434-202 study evaluating its lead pipeline candidate ATH434 for treating patients with multiple system atrophy, a rare neurodegenerative disease.

Zacks

Lexeo Down Despite Upbeat Rare Disease Gene Therapy Data

Shares of Lexeo Therapeutics (NASDAQ: LXEO) lost 26% on Monday after it reported positive interim data from two cohorts of the phase I/II SUNRISE-FA study evaluating LX2006, an investigational gene therapy for treating Friedreich ataxia (FA) cardiomyopathy.

Zacks

UniQure Soars on New Huntington's Disease Study Data

uniQure N.V. (NASDAQ: QURE) surged 76.5% on Jul 9 after it announced updated interim data, including up to 24 months of follow-up data, from 29 treated patients enrolled in the ongoing early to mid-stage studies of AMT-130 for Huntington's disease in the United States and EU.

Zacks

Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

Merck (NYSE: MRK) announced that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has unanimously voted to recommend MRK's newly approved 21-valent pneumococcal conjugate vaccine (PCV) Capvaxive.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

28.25M

Investing Cash Flow (TTM)

-27.00M

Financing Cash Flow (TTM)

1.85M

Free Cash Flow (TTM)

28.14M

Capital Expenditure (TTM)

-116.00K

Net Change in Cash (TTM)

3.10M

Analyst Trends and Forecast

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$101.39M

PE Ratio (TTM)

6.08

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.95

PB Ratio (TTM)

2.47

Earnings Yield % (TTM)

16.45%

Earnings Yield % (FWD)

-15.58%

EV / EBITDA (TTM)

3.31

Price / EBITDA (TTM)

7.13

Price / Free Cash Flow (TTM)

7.77

Book Value / Share

$0.94

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.28M

Debt to Equity

0.03

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$2.30

Volume / Avg.

188.67K / 254.90K

Day Range

$2.25 - $2.32

52 Wk Range

1.43 - 3.24

Market Cap

$216.53M

P/E Ratio

6.08

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.61%

Days to Cover

12.01

About Compugen Ltd

Sector

Health Care

Industry

Biotechnology

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Compugen (CGEN) stock?

You can purchase shares of Compugen (NASDAQ:CGEN) through any online brokerage.

View our list of the best stock brokerages

Who are Compugen (CGEN) competitors?

Other companies in Compugen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).

What is the forecast, or price target, for Compugen (CGEN) stock?

Compugen has a consensus price target of $4.60.

What is the current price for Compugen (CGEN)?

The stock price for Compugen (NASDAQ: CGEN) is $2.315 last updated October 5, 2026 at 3:46 PM EDT.

Does Compugen (CGEN) pay a dividend?

There are no upcoming dividends for Compugen.

When is Compugen (NASDAQ:CGEN) reporting earnings?

Compugen does not have any upcoming earnings scheduled.

Is Compugen (CGEN) going to split?

There is no upcoming split for Compugen.

What sector and industry does Compugen (CGEN) operate in?

Compugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Key Statistics

Open

$2.30

Volume / Avg.

188.67K / 254.90K

Day Range

$2.25 - $2.32

52 Wk Range

1.43 - 3.24

Market Cap

$216.53M

P/E Ratio

6.08

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.61%

Days to Cover

12.01

Recent Compugen Ltd. News

This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Avi Kapoor

Alterity Up on Interim Data From Advance MSA Study

Zacks

Lexeo Down Despite Upbeat Rare Disease Gene Therapy Data

Zacks

UniQure Soars on New Huntington's Disease Study Data

Zacks

Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

28.25M

Investing Cash Flow (TTM)

-27.00M

Financing Cash Flow (TTM)

1.85M

Free Cash Flow (TTM)

28.14M

Capital Expenditure (TTM)

-116.00K

Net Change in Cash (TTM)

3.10M

Analyst Trends and Forecast

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$101.39M

PE Ratio (TTM)

6.08

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.95

PB Ratio (TTM)

2.47

Earnings Yield % (TTM)

16.45%

Earnings Yield % (FWD)

-15.58%

EV / EBITDA (TTM)

3.31

Price / EBITDA (TTM)

7.13

Price / Free Cash Flow (TTM)

7.77

Book Value / Share

$0.94

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.28M

Debt to Equity

0.03

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Compugen (CGEN) stock?

You can purchase shares of Compugen (NASDAQ:CGEN) through any online brokerage.

View our list of the best stock brokerages

Who are Compugen (CGEN) competitors?

What is the forecast, or price target, for Compugen (CGEN) stock?

Compugen has a consensus price target of $4.60.

What is the current price for Compugen (CGEN)?

The stock price for Compugen (NASDAQ: CGEN) is $2.315 last updated October 5, 2026 at 3:46 PM EDT.

Does Compugen (CGEN) pay a dividend?

There are no upcoming dividends for Compugen.

When is Compugen (NASDAQ:CGEN) reporting earnings?

Compugen does not have any upcoming earnings scheduled.

Is Compugen (CGEN) going to split?

There is no upcoming split for Compugen.

What sector and industry does Compugen (CGEN) operate in?

Compugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Key Statistics

Open

$2.30

Volume / Avg.

188.67K / 254.90K

Day Range

$2.25 - $2.32

52 Wk Range

1.43 - 3.24

Market Cap

$216.53M

P/E Ratio

6.08

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.61%

Days to Cover

12.01

About Compugen Ltd

Sector

Health Care

Industry

Biotechnology

Compugen Ltd (CGEN) Stock Price, Quote, News & History

Compugen (CGEN) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent Compugen Ltd. News

This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Alterity Up on Interim Data From Advance MSA Study

Lexeo Down Despite Upbeat Rare Disease Gene Therapy Data

UniQure Soars on New Huntington's Disease Study Data

Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About Compugen Ltd

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy Compugen (CGEN) stock?

Who are Compugen (CGEN) competitors?

What is the forecast, or price target, for Compugen (CGEN) stock?

What is the current price for Compugen (CGEN)?

Does Compugen (CGEN) pay a dividend?

When is Compugen (NASDAQ:CGEN) reporting earnings?

Is Compugen (CGEN) going to split?

What sector and industry does Compugen (CGEN) operate in?

Key Statistics

Recent Compugen Ltd. News

This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Alterity Up on Interim Data From Advance MSA Study

Lexeo Down Despite Upbeat Rare Disease Gene Therapy Data

UniQure Soars on New Huntington's Disease Study Data

Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy Compugen (CGEN) stock?

Who are Compugen (CGEN) competitors?

What is the forecast, or price target, for Compugen (CGEN) stock?

What is the current price for Compugen (CGEN)?

Does Compugen (CGEN) pay a dividend?

When is Compugen (NASDAQ:CGEN) reporting earnings?

Is Compugen (CGEN) going to split?

What sector and industry does Compugen (CGEN) operate in?

Key Statistics

About Compugen Ltd